MULTIPLY ROBUST ESTIMATION FOR CAUSAL SURVIVAL ANALYSIS WITH TREATMENT NONCOMPLIANCE

Comparative effectiveness research frequently addresses a time-to-event outcome and can require unique considerations in the presence of treatment noncompliance. Motivated by the challenges in addressing noncompliance in the ADAPTABLE pragmatic clinical trial, we develop a multiply robust estimator to estimate the principal survival causal effects under the principal ignorability and monotonicity. The multiply robust estimator is consistent, even if one, and sometimes two, of the required models are misspecified. We apply the multiply robust method in the ADAPTABLE trial to evaluate the effect of low-vs. high-dose aspirin assignment on patients’ death and hospitalization from cardiovascular diseases. We find that, comparing to low-dose assignment, assignment to the high-dose leads to differential effects among always high-dose takers, compliers, and always low-dose takers. Such treatment effect heterogeneity contributes to the null intention-to-treatment effect. We further perform a formal sensitivity analysis for investigating the robustness of our causal conclusions under violation of two identification assumptions specific to noncompliance.

Duke Scholars

Author Lisa Wruck Biostatistics & Bioinformatics, Division of Biostatistics